Nasdaq-100 Index (NDX.NAS100)

Close: 19 433.00 (+218.16), Apr 25, 2025
Weak Positive

Low risk

Automatic technical analysis. Long term, Apr 25, 2025

Nasdaq-100 Index has broken the floor of the rising trend channel in the long term, which indicates a weaker initial rising rate. The index has support at points 16500 and resistance at points 22100. RSI diverges negatively against the price, which indicates danger of a reaction downwards. The index is overall assessed as technically slightly positive for the long term.

Recommendation one to six quarters: Weak Positive (Score: 29)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.98%0.00+1.14%
5 days0.003.27%0.00+6.43%
22 days0.008.05%0.00-4.22%
66 days0.0015.32%0.00-9.89%

More analyses of Nasdaq-100 Index

chart Nasdaq-100 Index (NDX) Candlesticks 22 Days
Candlesticks
chart Nasdaq-100 Index (NDX) Short term
Short term: Positive
chart Nasdaq-100 Index (NDX) Medium term
Medium term: Weak Positive
chart Nasdaq-100 Index (NDX) Long term
Long term: Weak Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.